bioRxivBioinformaticsPreprint
Optimisation-based modelling for drug discovery in malaria
Yutong LiiD, Jonathan Cardoso‐SilvaiD, Lazaros G. PapageorgiouiD, Sophia TsokaiD
Abstract
The discovery of new antimalarial medicines with novel mechanisms of action is important, given the ability of parasites to develop resistance to current treatments. Through the Open Source Malaria project that aims to discover new medications for malaria, several series of compounds have been obtained and tested. Analysis of the effective fragments in these compounds is important in order to derive means of optimal drug design and improve the relevant pharmaceutical application. We have previously reported a novel optimisation-based method for quantitative structure-activity relationship modelling, modSAR, that provides explainable modelling of ligand activity through a mathematical programming formulation. Briefly, modSAR clusters small molecules according to chemical similarity, determines the optimal split of each cluster into appropriate regions, and derives piecewise linear regression equations to predict the inhibitory effect of small molecules. Here, we report application of modSAR in the analysis of OSM anti-malarial compounds and illustrate how rules generated by the model can provide interpretable results for the contribution of individual ECFP fingerprints in predicting ligand activity, and contribute to the search for effective drug treatments.
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine Learning connects structure, bitterness & mechanism to antimalarial activity
S. Sambu·bioRxiv·Sep 8, 2023
- Machine learning approaches identify chemical features for stage-specific antimalarial compounds
A. van Heerden, G. Turon, … L.-M. Birkholtz·bioRxiv·Aug 15, 2023
- Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out
K. J. Dechering, M. Timmerman, … M. Duffey·bioRxiv·Jun 7, 2022
- Seeking an optimal dosing regimen for OZ439-DSM265 combination therapy for treating uncomplicated falciparum malaria
S. Dini, S. G. Zaloumis, … J. A. Simpson·bioRxiv·Nov 2, 2020
- Aryl N-acetamide compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1.
Coralie Boulet, Joyanta K. Modak, … Paul R. Gilson·bioRxiv·Mar 18, 2025
- Functional Phenotyping of MMV Pandemic Response Box Identifies Stage-specific inhibitors Against Blood stage Plasmodium
T P Akhila, K M Darsana, Rajesh Chandramohanadas·ACS Infectious DiseasesPeer-reviewed·Jul 11, 2025